Jan 29 |
Profound Medical (PROF) Soars 9.4%: Is Further Upside Left in the Stock?
|
Jan 4 |
Corcept (CORT) Surges 5.1%: Is This an Indication of Further Gains?
|
Jan 3 |
Lyell Immunopharma to Participate in 42nd Annual J.P. Morgan Healthcare Conference
|
Dec 19 |
Companies Like Lyell Immunopharma (NASDAQ:LYEL) Are In A Position To Invest In Growth
|
Nov 10 |
Lyell Immunopharma: Potential Solid Tumor Targeting With CAR-T And TIL
|
Nov 9 |
Lyell gets FDA orphan drug designation for melanoma drug candidate
|
Nov 9 |
Lyell Immunopharma Receives FDA Orphan Drug Designation for LYL845 for the Treatment of Melanoma
|
Nov 8 |
Lyell Immunopharma reports Q3 results
|
Nov 7 |
Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2023
|
Oct 31 |
Lyell Immunopharma Presentations at SITC Highlight New Nonclinical Data on Product Candidates and Innovative Technology to Shorten TIL Manufacturing
|